| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13742* | 2021 |
| Mir-34: a new weapon against cancer? G Misso, MT Di Martino, G De Rosa, AA Farooqi, A Lombardi, V Campani, ... Molecular therapy-nucleic acids 3, 2014 | 600 | 2014 |
| Mitochondria as playmakers of apoptosis, autophagy and senescence M Abate, A Festa, M Falco, A Lombardi, A Luce, A Grimaldi, S Zappavigna, ... Seminars in cell & developmental biology 98, 139-153, 2020 | 475 | 2020 |
| miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1 N Amodio, MT Di Martino, U Foresta, E Leone, M Lionetti, M Leotta, ... Cell death & disease 3 (11), e436-e436, 2012 | 194 | 2012 |
| In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma MT Di Martino, V Campani, G Misso, ME Gallo Cantafio, A Gulla, ... PloS one 9 (2), e90005, 2014 | 141 | 2014 |
| High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy M Rossi, B Rotblat, K Ansell, I Amelio, M Caraglia, G Misso, F Bernassola, ... Cell death & disease 5 (5), e1203-e1203, 2014 | 132 | 2014 |
| Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma N Amodio, MA Stamato, AM Gullà, E Morelli, E Romeo, L Raimondi, ... Molecular cancer therapeutics 15 (6), 1364-1375, 2016 | 129 | 2016 |
| Gastrointestinal hormones, intestinal microbiota and metabolic homeostasis in obese patients: effect of bariatric surgery A Federico, M Dallio, S Tolone, AG Gravina, V Patrone, M Romano, ... in vivo 30 (3), 321-330, 2016 | 94 | 2016 |
| Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid G Misso, M Porru, A Stoppacciaro, M Castellano, F De Cicco, C Leonetti, ... Cancer biology & therapy 13 (14), 1491-1500, 2012 | 92 | 2012 |
| Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell … P Correale, M Marra, C Remondo, C Migali, G Misso, FP Arcuri, ... European journal of cancer 46 (9), 1703-1711, 2010 | 89 | 2010 |
| Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours AM Cossu, L Mosca, S Zappavigna, G Misso, M Bocchetti, F De Micco, ... International Journal of Molecular Sciences 20 (14), 3444, 2019 | 83 | 2019 |
| Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse V Nardone, C Botta, M Caraglia, EC Martino, MR Ambrosio, T Carfagno, ... Cancer biology & therapy 17 (11), 1213-1220, 2016 | 81 | 2016 |
| Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients EC Martino, G Misso, P Pastina, S Costantini, F Vanni, C Gandolfo, ... Cell death discovery 2 (1), 1-8, 2016 | 81 | 2016 |
| Molecular targets for the treatment of multiple myeloma M Rossi, M Teresa Di Martino, E Morelli, M Leotta, A Rizzo, A Grimaldi, ... Current cancer drug targets 12 (7), 757-767, 2012 | 73 | 2012 |
| Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells A Grimaldi, D Santini, S Zappavigna, A Lombardi, G Misso, M Boccellino, ... Cancer biology & therapy 16 (4), 567-579, 2015 | 66 | 2015 |
| Transferrin‐conjugated SNALPs encapsulating 2′‐O‐methylated miR‐34a for the treatment of multiple myeloma I Scognamiglio, MT Di Martino, V Campani, A Virgilio, A Galeone, A Gullà, ... BioMed research international 2014 (1), 217365, 2014 | 62 | 2014 |
| Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic … P Correale, C Botta, MS Rotundo, A Guglielmo, R Conca, A Licchetta, ... Journal of Immunotherapy 37 (1), 26-35, 2014 | 62 | 2014 |
| Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action C Irace, G Misso, A Capuozzo, M Piccolo, C Riccardi, A Luchini, ... Scientific reports 7 (1), 45236, 2017 | 58 | 2017 |
| Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways M Caraglia, M Marra, P Tagliaferri, SWJ Lamberts, S Zappavigna, G Misso, ... Current cancer drug targets 9 (5), 690-704, 2009 | 57 | 2009 |
| Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer M Piccolo, G Misso, MG Ferraro, C Riccardi, A Capuozzo, MR Zarone, ... Scientific Reports 9 (1), 7006, 2019 | 56 | 2019 |
